首页> 外文期刊>Journal of diabetes and its complications >Diabetic sclerosing lymphocytic lobulitis of the breast.
【24h】

Diabetic sclerosing lymphocytic lobulitis of the breast.

机译:乳房糖尿病性硬化性淋巴细胞性小叶炎。

获取原文
获取原文并翻译 | 示例
           

摘要

Diabetic sclerosing lymphocytic lobulitis of the breast (SLLB) as a complication of long standing diabetes is a benign disease without known tendency to malignant evolution. Clinically, it is characterized by solitary or multiple rock-hard discrete lesion(s) in one or both breasts, usually in a subareolar site, but may appear equally in any part of the breast. Mammographically and morphologically, this lesion simulates cancer. The lesion may recur after excision in the same site or in another location of the ipsilateral or the contralateral breast. Awareness of this entity, establishment of the diagnosis by open biopsy or by core needle biopsy may spare the need for repeated wide excisions and the resulting distortion of the breast architecture. The aim of this review is to arouse the awareness of the physicians and surgeons to this possibility when they find a similar lesion in the breast of a diabetic patient.
机译:长期以来患有糖尿病的糖尿病性硬化性乳腺淋巴细胞性小叶炎(SLLB)是一种良性疾病,尚无恶性演变的已知趋势。在临床上,它的特征是一个或两个乳房(通常在乳晕下部位)出现单个或多个坚硬的离散病变,但可能在乳房的任何部位均等出现。在乳腺和形态上,该病灶可模拟癌症。切除后,病变可能会在同侧或对侧乳房的同一部位或另一部位复发。意识到这一点,通过开放式活检或芯针活检确定诊断可以避免重复进行大范围切除以及由此导致的乳房结构变形。这篇综述的目的是引起医师和外科医生在糖尿病患者的乳房中发现类似病变时意识到这种可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号